All big pharma execs ran as far away and fast as possible after May 2022 presentation. Prepare for either an increase in authorized share count or reverse in the coming months, if not sooner.
Kam, many longs will be happy with your suggested buyout price. I will be happy with it and reinvest the surplus into the new company owning the dcvax platform. this time the growth will be quicker too and i dont need to deal with ex and his gang.
Immediately the terms may be disgusted and hopefully with more than one suitor. IMO we will hear about offer(s) within 3-4 months. IMO the low end estimate $14 and the high $25. I like the $18 number. Multiple suitors could easily push it over $20.
Approval IMO is this year and then .... LP is ready